BUDDI.AI

BUDDI.AI's learned engine interprets unstructured medical records and turns clinical context into data that coding and other applications can use. CODING.AI applies that engine to procedure and diagnosis coding, while CLAIMS.AI predicts denial risk from prior decisions and payment behavior. These are central capabilities within a broader suite that also handles registration, eligibility, billing workflows and patient payments.

The company calls its proprietary language technology Medical Language Processing and combines it with a contextual knowledge graph. Removing that learned interpretation would remove the main coding and extraction capabilities, although portions of the surrounding financial workflow could continue as conventional software.

The coding interface supports distinct roles for coding managers, coders and auditors, along with status monitoring and an analytics dashboard. Those features provide an operational review structure around automated coding and allow specialist staff to inspect work. The product targets automation of a portion of volume rather than claiming that every chart is coded without error.

Its accuracy guarantee is explicitly at least 95%, and language about helping eliminate human error does not establish perfect output. Public workflow descriptions do not identify a confidence cutoff, a mandatory exception queue or the exact conditions that stop a code from being committed. The point of required human approval remains unspecified.

The technical account combines proprietary Medical Language Processing with a Clinical Contextual Graph. Source records are structured, clinical entities are identified and relationships are assembled before downstream applications use the resulting representation. CLINICAL.AI also describes vision based table detection, OCR, correction of missing words and longitudinal timelines.

BUDDI.AI identifies deep learning and more than 40 million training records, with IIT Madras named as a research partner. This gives a recognizable technical approach beyond a generic AI label. Model names, architecture versions, training provenance and production update practices remain unspecified, and the automatic updating of medical code sets is separate from updating the learned models themselves.

The main learned component is identified as BUDDI.AI's proprietary Medical Language Processing engine and contextual graph technology. The company names IIT Madras as a research partner, Microsoft Azure as its cloud provider and Redox as an integration partner. This distinguishes model ownership, infrastructure and data transport without treating all three as external inference vendors.

The website privacy notice describes service providers in general terms rather than a complete list for patient chart processing. Public material does not enumerate every model dependency or subcontractor, or give retention and training terms for each recipient of clinical data. The central model is identifiable, while the full processing chain remains incomplete.

The company reports at least 95% coding accuracy, automation of at least 70% of chart volume and coding savings of at least 30%. Its homepage also lists 270 provider sites and 48 million annual production charts. These figures describe claimed performance and scale, with no named evaluation population, reference coding process, measurement date or error analysis attached. The use case page has testimonials from unnamed revenue cycle and compliance organizations.

A 2026 industry report establishes continued market presence, but does not validate the product's accuracy. The stated contractual accuracy guarantee is a commercial commitment and does not substitute for a study of actual coding outcomes.

Clinical charts are processed by the language engine and converted into a contextual graph for downstream applications. Security statements describe AES 256 encryption, controlled user roles and an option to run the platform in a customer's private cloud. The company also says that more than 40 million medical records were used to train its algorithms.

It does not explain the permissions or deidentification applied to that training collection, whether current customer records enter shared training, or how long source charts and derived data remain. The public materials also lack a defined AI safety incident process, hallucination mitigation specification and model specific guardrail testing. General security assurances leave those AI handling questions unresolved.

The company states that its platform is HIPAA compliant and offers to sign a business associate agreement with customers and partners. The public privacy notice names Claritrics Inc., doing business as BUDDI.AI, and primarily addresses website visitors, contact information, advertising and communications. It does not supply the agreement governing patient charts processed by the coding service.

Public materials leave the agreement's product coverage, subcontractor obligations and breach terms unspecified. Azure hosting and encryption describe technical safeguards, but do not settle the contractual handling of patient information. The public posture therefore contains an explicit compliance claim and BAA offer with incomplete service level privacy terms.

BUDDI.AI explicitly states that its applications, including CODING.AI, are SOC 2 compliant. Its security account adds AES 256 encryption and separate user roles, alongside Azure hosting and private cloud deployment options. The claim concerns the company's applications as well as the hosting environment, but no public audit report, report period, auditor name or examination type accompanies it.

The public record therefore establishes a vendor assurance claim with limited independent detail. It does not establish a current SOC 2 Type II examination or an ISO certification. Microsoft's infrastructure controls cannot resolve the missing scope of BUDDI.AI's own operational assessment.

The primary coding and revenue cycle functions concern billing, documentation and administrative data exchange. The broader CLINICAL.AI offer, however, includes diagnostic error prevention, clinical decision support and medical image analysis among its uses. Its extraction and summarization capabilities can therefore support decisions beyond billing.

Public product pages do not identify a cleared medical device, an application specific regulatory pathway or a boundary that limits these clinical uses to nondevice functions. Coding compliance with CMS edits concerns reimbursement rules rather than FDA authorization. The unclear relationship between the administrative platform and the advertised clinical decision functions leaves the regulatory scope of the full offering unresolved.

Medical coding rules are maintained through code set updates and checks such as NCCI edits, while managers and auditors can monitor operational work. Those controls address coding compliance and workflow review. They do not describe how learned model behavior is assessed across specialties, record formats or patient populations.

The company's values emphasize trust, security and collaboration, but no AI governance policy, model review framework or subgroup evaluation accompanies those statements. Training on a large chart collection does not establish how representative that collection is or where errors concentrate. A public account of model approval, monitoring and corrective action is absent from the current technology and product material.

CODING.AI carries an explicit contractual guarantee of at least 95% coding accuracy, with code quality tied to CMS, payer and client requirements. The company also promises minimum coding cost savings and says service level agreements cover performance. Unlike an uptime promise alone, the accuracy commitment is attached directly to the product's output.

Public marketing does not disclose how sampling works, which charts are excluded, how disputes are adjudicated or what credit or remediation follows a shortfall. A support phone number and trouble ticket form provide an operational contact. The enforceable measurement and remedy details remain in the customer's negotiated agreement rather than the public product page.

CODING.AI accepts charts through APIs, secure file transfer and HL7, and the platform describes HL7 and X12N support for record and billing connections. Redox is named as a middleware partner for standardized health data exchange. These details identify transport methods and a plausible integration route. The public pages do not name an EHR customer deployment, show a verified marketplace listing with its exact data permissions or explain whether codes are written back into a live system.

General claims about compatibility with major EMRs do not establish those details. The available evidence supports standards and middleware connectivity, with production direction and system specific depth unresolved.

The platform uses Microsoft Azure and can be hosted by BUDDI.AI or moved into the customer's secure private cloud. Its Secure Cloud Container supports Docker based deployment into a HIPAA oriented environment. That provides a concrete choice about who operates the environment, beyond a browser only service with an unnamed host. The public account does not identify available Azure regions, default storage locations, backup geography or support access across borders.

New York headquarters and a Chennai office are corporate locations rather than residency guarantees. Tenant separation in the vendor hosted service and the precise controls inherited in a customer deployment are also not fully described.

Customers engage the company for a demonstration and a scoped deployment of coding, billing or other modules. CODING.AI is available as an API or through a browser workflow, and hosting can be supplied by BUDDI.AI or placed in a customer's private cloud. That identifies the main delivery choices and sources of project scope. A public price per chart, subscription minimum, tier schedule or implementation fee is not available.

Claims of lower coding expenditure and contractual savings describe an expected commercial outcome rather than a fee. The site also links to an API marketplace, but its public marketing pages do not provide a usable rate card.

CODING.AI is aimed at physician and facility coding across outpatient specialties. The wider platform addresses providers, revenue cycle firms, payers, health information exchanges and life sciences organizations. Payer examples include HCC coding, record review and payment audits; provider examples include documentation improvement and prior authorization. Those are clearly described intended settings.

Performance statements and customer testimonials do not identify named clinical specialties or named production customers with corresponding evaluation results. Training across many specialties and the number of provider sites indicate breadth of claimed experience, but do not establish consistent accuracy in each setting or support for inpatient coding beyond the product's stated outpatient scope.